AK

Andrei W. Konradi

Head of Chemistry at Vivace Therapeutics

Andrei W. Konradi, Ph.D. is head of chemistry at Vivace Therapeutics. Prior to joining Vivace, he was the principal of Konradi Molecular and senior director of medicinal chemistry at Elan Pharmaceuticals. During his career, Dr. Konradi has conceived of new compound classes that have led to six drug candidates tested in humans, including four integrin inhibitors for autoimmune diseases and two protease inhibitors for Alzheimer’s. He has authored 38 peer-reviewed journal articles and is an inventor on 61 U.S. patents. Dr. Konradi completed a B.S. in chemistry at Massachusetts Institute of Technology and a doctorate in organic chemistry at Berkeley; he then served as postdoctoral fellow in bioorganic chemistry at The Scripps Research Institute.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


V

Vivace Therapeutics

Vivace Therapeutics is a venture-backed, oncology-focused portfolio-based drug discovery and development company, based in San Mateo, California. Its programs include both small molecule programs targeting the YAP pathway, and bi-specific programs.


Industries

Employees

1-10

Links